NCT05239208
Completed
Not Applicable
Effects of Oral Nutritional Supplementation With Dietary Counseling in 24-60 Months Old Children at Risk of Undernutrition
ConditionsUndernutrition
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Undernutrition
- Sponsor
- Abbott Nutrition
- Enrollment
- 330
- Locations
- 1
- Primary Endpoint
- Weight-for-Age Z-Score
- Status
- Completed
- Last Updated
- 3 years ago
Overview
Brief Summary
This prospective, randomized, controlled study will evaluate the effects of oral nutritional supplementation plus dietary counseling versus dietary counseling alone in children at nutritional risk.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Children 24-60 months old
- •Undernourished or at risk of undernutrition according to the WHO Growth Standards.
- •Child's parent(s)/legal guardian (LG) is willing to abstain from giving additional non-study ONS other than the study product during the study intervention period.
- •Child's parent(s)/LG is able and willing to follow study procedures and record data in parent diary and complete any forms or assessments needed throughout the study.
- •Child's parent(s)/LG is not planning to relocate during the study period.
- •Child's parent(s)/LG has voluntarily signed and dated an Informed Consent Form (ICF), approved by an Independent Ethics Committee/Institutional Review Board (IEC/IRB) or other applicable privacy regulation authorization prior to any participation in the study.
Exclusion Criteria
- •Participant participates in another study that has not been approved as a concomitant study.
- •Child is known to have galactosemia, be allergic or intolerant to any ingredient found in the study product.
- •Child is currently drinking an Abbott product(s).
- •Child had a history of preterm delivery, defined as a birth before 37 completed weeks of gestation as reported by parent(s)/LG.
- •Child had birth weight \< 2500 g or \> 4000 g.
- •Child whose either parent has BMI ≥ 27.5 kg/m2
- •Child has continuous oral nutrition supplement (ONS) usage for at least 15 days in the past 1 month prior to screening. The standard ONS formula usually has an energy density of at least 1 kcal/mL, containing protein, carbohydrate and/or fat, as well as a wide range of micronutrients to supplement or use as the sole source of nutrition.
- •Child has current acute or chronic infections including but not restricted to respiratory infections, diarrhea, acute and chronic Hepatitis B or C, HIV infection or tuberculosis.
- •Child has been diagnosed with the following according to medical records or report by parent(s)/LG or the clinician's judgment:
- •Severe gastrointestinal disorders such as celiac disease, short bowel syndrome, pancreatic insufficiency, or cystic (Exception: Intestinal parasites infection)
Outcomes
Primary Outcomes
Weight-for-Age Z-Score
Time Frame: Baseline to 120 Days
Change in weight-for-age z-score
Secondary Outcomes
- Height(Baseline to 240 Days)
- Weight(Baseline to 240 Days)
- MUAMC Measurement Calculations(Baseline to 240 Days)
- Weight-for-Height Measurement Calculations(Baseline to 240 Days)
- Mid-Upper-Arm Circumference (MUAC)(Baseline to 240 Days)
- Dietary Intake(Baseline to 240 Days)
- BMI-for-Age Measurement Calculations(Baseline to 240 Days)
- Height-for-Age Measurement Calculations(Baseline to 240 Days)
- Appetite(Baseline to 240 Days)
Study Sites (1)
Loading locations...
Similar Trials
Completed
Not Applicable
Oral Nutritional Supplementation in Children at Risk of UndernutritionUndernutritionNCT05161000Abbott Nutrition279
Not yet recruiting
Phase 4
Beneficial Effects of Vitamin D Combined With Oral Iron Supplementation in Patients With Chronic Heart Failure and Iron DeficiencyHeart FailureIron-deficiencyHeart Failure, SystolicHeart Failure NYHA Class IIHeart Failure NYHA Class IIIVitamin D DeficiencyNCT05702970University of Padova258
Terminated
Early Phase 1
Vitamin D Supplementation in Women With DCIS and/or LCISBreast CancerNCT02936999Inova Health Care Services8
Recruiting
Phase 4
Oral Vitamin D Supplementation Prevent Peritoneal Dialysis-related PeritonitisPeritoneal Dialysis-associated PeritonitisVitamin D DeficiencyNCT05860270Peking University First Hospital176
Completed
Phase 2
The Effects of Oral Vitamin D Supplementation on the Prevention of Peritoneal Dialysis-related PeritonitisPeritoneal Dialysis-associated PeritonitisVitamin D DeficiencyNCT03264625Peking University First Hospital60